TP63 and prostate cancer: In one recently described model, cell fractionation studies of CWR22 human prostate cancer xenograft tumors demonstrated that tumor protospheres containing CK8+/CK5+/AR-/TP63- cells gave rise to CK8+/CK5-/AR+ tumors [10].